Histological examination of skulls of 3- to 7-month-old human fetuses reveals in the fourth month of fetal life the development of a morphologically distinctive tissue in the area between the frontal and parietal bones. In this particular area, the pericranium tends to bulge outward while the dura mater shows the same in an inward direction. Consequently, a spindle-shaped blastema is enclosed. This spindle-like structure is only temporarily present; by about the sixth month of fetal life it has disappeared. Secondly, it was observed that prior to the development of this blastema mainly undifferentiated mesenchymal cells and only few fibroblasts are present in the area between the approaching ossification centres. In the full-grown blastema both types of cells are present in about equal numbers. However, once the blastema has been formed, fibroblasts predominate over mesenchymal cells. This tissue structure is also clearly distinguishable in the developing fetal rat skull. In this species, however, the spindle-shaped blastema appears at a later phase of fetal development, i.e. at about the 20th day. In both species, man and rat, the temporary presence of this blastema is not confined to the presumptive coronal suture only, but is demonstrable as well in other cranial sutures.

Keywords:
Desmocranium, Coronal suture, Blastema, Fibroblast, Undifferentiated mesenchymal cell, Dura mater, Pericranium, Collagen fibre, Extracranial direction, Intracranial direction
This content is only available via PDF.
© 1975 S. Karger AG, Basel
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.